{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:40:58Z","timestamp":1793313658204,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006955","name":"National Institutes of Health Office of Extramural Research","doi-asserted-by":"publisher","award":["R15GM110602"],"award-info":[{"award-number":["R15GM110602"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.bmc.2021.116179","type":"journal-article","created":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T07:58:37Z","timestamp":1619510317000},"page":"116179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["A novel GSK-3 inhibitor binds to GSK-3\u03b2 via a reversible, time and Cys-199-dependent mechanism"],"prefix":"10.1016","volume":"40","author":[{"given":"Davoud","family":"Ghazanfari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboubeh S.","family":"Noori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"Bergmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer V.","family":"Hines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly D.","family":"McCall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas J.","family":"Goetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2021.116179_b0005","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1002\/j.1460-2075.1990.tb07419.x","article-title":"Molecular cloning and expression of glycogen synthase kinase-3\/Factor A","volume":"9","author":"Woodgett","year":"1990","journal-title":"EMBO J"},{"key":"10.1016\/j.bmc.2021.116179_b0010","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1432-1033.1980.tb06059.x","article-title":"Glycogen synthase kinase-3 from rabbit skeletal muscle separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase","volume":"107","author":"Embi","year":"1980","journal-title":"Eur J Biochein"},{"key":"10.1016\/j.bmc.2021.116179_b0015","first-page":"167","volume":"vol. 6","author":"Woodgett","year":"2017"},{"key":"10.1016\/j.bmc.2021.116179_b0020","doi-asserted-by":"crossref","first-page":"106464","DOI":"10.1016\/j.leukres.2020.106464","article-title":"Evidence that knock down of GSK-3\u03b2 in Chronic Myelogenous Leukemia cells augments IFN-\u03b3-induced apoptosis","volume":"99","author":"Kauffman","year":"2020","journal-title":"Leuk. Res"},{"key":"10.1016\/j.bmc.2021.116179_b0025","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s11064-006-9128-5","article-title":"Glycogen synthase kinase-3 (GSK3): Inflammation, diseases, and therapeutics","volume":"32","author":"Jope","year":"2007","journal-title":"Neurochem Res"},{"key":"10.1016\/j.bmc.2021.116179_b0030","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.bbapap.2009.09.010","article-title":"Substrate competitive GSK-3 inhibitors - strategy and implications","volume":"1804","author":"Eldar-Finkelman","year":"2010","journal-title":"Biochimica et Biophysica Acta - Proteins and Proteomics"},{"key":"10.1016\/j.bmc.2021.116179_b0035","doi-asserted-by":"crossref","first-page":"45937","DOI":"10.1074\/jbc.M306268200","article-title":"Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418","volume":"278","author":"Bhat","year":"2003","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.bmc.2021.116179_b0040","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/nbt.2017","article-title":"Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity","volume":"29","author":"Anastassiadis","year":"2011","journal-title":"Nat. Biotechnol"},{"key":"10.1016\/j.bmc.2021.116179_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnmol.2011.00032","article-title":"GSK-3 inhibitors: preclinical and clinical focus on CNS","volume":"4","author":"Eldar-Finkelman","year":"2011","journal-title":"Front. Mol. Neurosci"},{"key":"10.1016\/j.bmc.2021.116179_b0050","first-page":"315","article-title":"Clinically relevant GSK-3\u03b2 inhibitor 9-ING-41 is active as a single agent and in combination with other antitumor therapies in human renal cancer","volume":"45","author":"Anraku","year":"2020","journal-title":"Int. J. Mol. Med"},{"key":"10.1016\/j.bmc.2021.116179_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-56461-4","article-title":"9-ING-41, a small molecule inhibitor of GSK-3beta, potentiates the effects of anticancer therapeutics in bladder cancer","volume":"9","author":"Kuroki","year":"2019","journal-title":"Sci. Rep"},{"key":"10.1016\/j.bmc.2021.116179_b0060","doi-asserted-by":"crossref","first-page":"7103","DOI":"10.1021\/jm040895g","article-title":"SAR and 3D-QSAR studies on thiadiazolidinone derivatives: Exploration of structural requirements for glycogen synthase kinase 3 inhibitors","volume":"48","author":"Martinez","year":"2005","journal-title":"J. Med. Chem"},{"key":"10.1016\/j.bmc.2021.116179_b0065","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JAD-141959","article-title":"A phase II trial of tideglusib in alzheimer\u2019s disease","volume":"45","author":"Lovestone","year":"2015","journal-title":"J. Alzheimer\u2019s Dis"},{"key":"10.1016\/j.bmc.2021.116179_b0070","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1074\/jbc.M111.306472","article-title":"Evidence for irreversible inhibition of glycogen synthase kinase-3\u03b2 by tideglusib","volume":"287","author":"Dom\u00ednguez","year":"2012","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.bmc.2021.116179_b0075","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1152\/ajpcell.00061.2019","article-title":"Identification of a novel selective and potent inhibitor of glycogen synthase kinase-3","volume":"317","author":"Noori","year":"2019","journal-title":"Am. J. Physiol. - Cell Physiol"},{"key":"10.1016\/j.bmc.2021.116179_b0080","doi-asserted-by":"crossref","first-page":"173340","DOI":"10.1016\/j.ejphar.2020.173340","article-title":"Modulation of LPS-induced inflammatory cytokine production by a novel glycogen synthase kinase-3 inhibitor","volume":"883","author":"Noori","year":"2020","journal-title":"Eur. J. Pharmacol"},{"key":"10.1016\/j.bmc.2021.116179_b0085","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nmeth747","article-title":"A multiplexed homogeneous fluorescence-based assay for protein kinase activity in cell lysates","volume":"2","author":"Shults","year":"2005","journal-title":"Nat. Methods"},{"key":"10.1016\/j.bmc.2021.116179_b0090","doi-asserted-by":"crossref","first-page":"12821","DOI":"10.1021\/ja8046188","article-title":"Recognition-domain focused chemosensors: Versatile and efficient reporters of protein kinase activity","volume":"130","author":"Lukovi\u0107","year":"2008","journal-title":"J. Am. Chem. Soc"},{"key":"10.1016\/j.bmc.2021.116179_b0095","doi-asserted-by":"crossref","first-page":"14248","DOI":"10.1021\/ja0380502","article-title":"Versatile fluorescence probes of protein kinase activity","volume":"125","author":"Shults","year":"2003","journal-title":"J. Am. Chem. Soc"},{"key":"10.1016\/j.bmc.2021.116179_b0100","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.1073\/pnas.0600445103","article-title":"Targeted covalent inactivation of protein kinases by resorcylic acid lactone polyketides","volume":"103","author":"Schirmer","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.bmc.2021.116179_b0105","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ab.2011.05.029","article-title":"Impact of enzyme concentration and residence time on apparent activity recovery in jump dilution analysis","volume":"416","author":"Copeland","year":"2011","journal-title":"Anal. Biochem"},{"key":"10.1016\/j.bmc.2021.116179_b0110","author":"Copeland","year":"2013"},{"key":"10.1016\/j.bmc.2021.116179_b0115","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ab.2012.01.006","article-title":"Reducing agents affect inhibitory activities of compounds: Results from multiple drug targets","volume":"423","author":"Lee","year":"2012","journal-title":"Anal. Biochem"},{"key":"10.1016\/j.bmc.2021.116179_b0120","doi-asserted-by":"crossref","first-page":"12624","DOI":"10.1021\/ja505194w","article-title":"Design of reversible, cysteine-targeted michael acceptors guided by kinetic and computational analysis","volume":"136","author":"Krishnan","year":"2014","journal-title":"J. Am. Chem. Soc"},{"issue":"870","key":"10.1016\/j.bmc.2021.116179_b0125","first-page":"1","article-title":"Identification of a first in class GSK3-alpha selective inhibitor as a new differentiation therapy for AML","volume":"126","author":"Benajiba","year":"2015","journal-title":"Blood"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089621001875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089621001875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:14:39Z","timestamp":1760836479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089621001875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":25,"alternative-id":["S0968089621001875"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116179","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel GSK-3 inhibitor binds to GSK-3\u03b2 via a reversible, time and Cys-199-dependent mechanism","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116179","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116179"}}